These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17696194)

  • 21. Prolonged preleukemic phase of chronic myelogenous leukemia.
    Hudnall SD; Northup J; Panova N; Suleman K; Velagaleti G
    Exp Mol Pathol; 2007 Dec; 83(3):484-9. PubMed ID: 17931622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
    Jha CB; Kucheria K; Choudhary VP
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of CD7 on CD34+ cells is not linked to deletion of derivative chromosome 9 or lack of dendritic cells in chronic myeloid leukaemia.
    Fløisand Y; Normann AP; Heim S; Lund-Johansen F; Tjønnfjord GE
    Scand J Clin Lab Invest; 2008; 68(2):93-8. PubMed ID: 17852828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imatinib resistance in a novel translocation der(17)t(1;17)(q25;p13) with loss of TP53 but without BCR/ABL kinase domain mutation in chronic myelogenous leukemia.
    Yamamoto K; Yakushijin K; Nishikawa S; Minagawa K; Katayama Y; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2008 May; 183(1):77-81. PubMed ID: 18474303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Klco JM; Kreisel FH; Zehnbauer BA; Kulkarni S; Hassan A; Frater JL
    Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
    Boultwood J; Perry J; Zaman R; Fernandez-Santamaria C; Littlewood T; Kusec R; Pellagatti A; Wang L; Clark RE; Wainscoat JS
    Leukemia; 2010 Jun; 24(6):1139-45. PubMed ID: 20410925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
    Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
    Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CML.
    Brizard F; Cividin M; Villalva C; Guilhot F; Brizard A
    Leuk Res; 2004 Apr; 28(4):345-8. PubMed ID: 15109532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.
    Stoklosa T; Poplawski T; Koptyra M; Nieborowska-Skorska M; Basak G; Slupianek A; Rayevskaya M; Seferynska I; Herrera L; Blasiak J; Skorski T
    Cancer Res; 2008 Apr; 68(8):2576-80. PubMed ID: 18413724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
    Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic myelogenous leukemia occurring in two brothers diagnosed 26 years apart.
    Lessen DS; Novoselac AV; Hellman G; Tapia A; Ratner LH; Najfeld V
    Cancer Genet Cytogenet; 2005 Jul; 160(1):73-5. PubMed ID: 15949574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
    Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
    Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-analysis of the cell line NALM-1 karyotype by GTG-banding, spectral karyotyping, and whole chromosome painting.
    Pelz AF; Weilepp G; Wieacker PF
    Cancer Genet Cytogenet; 2005 Jan; 156(1):59-61. PubMed ID: 15588857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic myeloid leukaemia as a model of disease evolution in human cancer.
    Melo JV; Barnes DJ
    Nat Rev Cancer; 2007 Jun; 7(6):441-53. PubMed ID: 17522713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24).
    Lin P; Lennon PA; Yin CC; Abruzzo LV
    Cancer Genet Cytogenet; 2009 Sep; 193(2):119-22. PubMed ID: 19665075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic significance of additional chromosomal abnormalities in Ph positive bone marrow cells in chronic myeloid leukemia].
    Lozyns'ka MP; Masliak ZV; Lukavets'kyĭ LM; Tsiapka OM; Lozyns'kyĭ RIu
    Tsitol Genet; 2005; 39(1):26-33. PubMed ID: 16018175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dual colour dual fusion fluorescence in situ hybridisation study on the genesis of complex variant translocations in chronic myelogenous leukaemia.
    So CC; Wan TS; Yip SF; Chan LC
    Oncol Rep; 2008 May; 19(5):1181-4. PubMed ID: 18425374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.